-
Mashup Score: 8Support my Velocity fundraiser and help Columbia solve cancer. - 2 month(s) ago
On October 6, I’ll be participating in Velocity. I’ve committed to raising crucial funds to help solve cancer at Columbia’s Herbert Irving Comprehensive Cancer Center and I can’t do it without you. Will you support me with a donation today?
Source: www.velocityride.orgCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 42
Sodium-glucose cotransporter-2 inhibitors (SGLT2i) have demonstrated benefit in patients with heart failure, but minimal data exists around the use of these medications in amyloid light-chain cardiomyopathy (AL-CM). We performed a retrospective study assessing the safety and efficacy of SGLT2i in AL-CM.
Source: onlinejcf.comCategories: General Medicine News, Partners & KOLsTweet-
Safety and Efficacy of SGLT2 Inhibitors in AL Amyloidosis @MathewMaurer @CAMPamyloidosis https://t.co/00XBXqzt0Z https://t.co/h994mWj4Z8 https://t.co/pD0v7dszWw
-
-
Mashup Score: 13
The Glasgow prognostic score (GPS) and CAR-HEMATOTOX (CAR-HT) score identify multiple myeloma (MM) patients at high risk for immune-mediated toxicity and early mortality with cellular immunotherapy. …
Source: onlinelibrary.wiley.comCategories: General Medicine News, Partners & KOLsTweet-
RT @MeeraMohanMD: British Journal of Haematology | Wiley Online Library https://t.co/54ZO37zYyz Can baseline GPS (CRP, albumin) and CART H…
-
-
Mashup Score: 10
The Glasgow prognostic score (GPS) and CAR-HEMATOTOX (CAR-HT) score identify multiple myeloma (MM) patients at high risk for immune-mediated toxicity and early mortality with cellular immunotherapy. …
Source: onlinelibrary.wiley.comCategories: General Medicine News, Partners & KOLsTweet-
RT @MeeraMohanMD: British Journal of Haematology | Wiley Online Library https://t.co/54ZO37zYyz Can baseline GPS (CRP, albumin) and CART H…
-
-
Mashup Score: 28MHG India - 3 month(s) ago
Medical HTML Template
Source: mhgindia.comCategories: General Medicine News, Partners & KOLsTweet-
Excited to join the Mumbai Hematology Group (https://t.co/JYQkTLfUcQ) today for a virtual talk on Bispecific Antibodies in the management of #MultipleMyeloma and AL #Amyloidosis! Link for joining: https://t.co/cZjWA0MZTH #mmsm https://t.co/LkpDPDxCvE
-
-
Mashup Score: 34
Sodium-glucose cotransporter-2 inhibitors (SGLT2i) have demonstrated benefit in patients with heart failure, but minimal data exists around the use of these medications in amyloid light-chain cardiomyopathy (AL-CM). We performed a retrospective study assessing the safety and efficacy of SGLT2i in AL-CM.
Source: onlinejcf.comCategories: General Medicine News, Partners & KOLsTweet-
Safety and Efficacy of SGLT2 Inhibitors in AL Amyloidosis @MathewMaurer @CAMPamyloidosis https://t.co/00XBXqzt0Z https://t.co/h994mWj4Z8 https://t.co/pD0v7dszWw
-
-
Mashup Score: 26Graded Organ Response and Progression Criteria for Kidney Immunoglobulin Light Chain Amyloidosis - 4 month(s) ago
This cohort study examines graded kidney response criteria and their association with kidney and overall survival for patients with kidney light chain amyloidosis.
Source: jamanetwork.comCategories: General Medicine News, Partners & KOLsTweet-
Graded Kidney Response Criteria in AL #Amyloidosis! With improving therapies, a 30% or 50% reduction in proteinuria is no longer good enough. Impressive collaborative study by Dr. Muchtar and @MorieGertz! https://t.co/DqGkx2MrOo
-
-
Mashup Score: 60Outcomes of venetoclax-based therapy in patients with t(11;14) light chain amyloidosis after failure of daratumumab-based therapy - 5 month(s) ago
Daratumumab’s incorporation in the upfront treatment of light chain (AL) amyloidosis has led to daratumumab (dara) refractoriness early in disease course. Patients who experience relapse or have su…
Source: www.tandfonline.comCategories: General Medicine News, Partners & KOLsTweet-
Our multicenter study led by @DimaDanai @MSHughes_MD on Venetoclax outcomes after Dara-failure in AL #Amyloidosis: VGPR rate ~90% Cardiac Organ RR~70% ~1 in 4 required another LoT at a median f/u of 22 mo. No treatment-related deaths! https://t.co/AiJHzttn4x
-
-
Mashup Score: 24TIMING AND OUTCOMES OF SECOND LINE THERAPY IN THE ERA OF... by Abdul-Hamid Bazarbachi - 6 month(s) ago
EHA Library; Bazarbachi A. Jun 13 2024; 421013;
Source: library.ehaweb.orgCategories: General Medicine News, Partners & KOLsTweet-
Timing and Outcomes of 2nd line therapy in the era of frontline Dara-VCd in AL #Amyloidosis-Our experience @CAMPamyloidosis to be presented at #EHA24 by @abazarbachi! @SLentzsch https://t.co/6o7lBqkzR8
-
-
Mashup Score: 3Distant Thunder (1973) ⭐ 7.9 | Drama - 6 month(s) ago
1h 41m | Not Rated
Source: m.imdb.comCategories: General Medicine News, Hem/OncsTweet-
@nihardesai7 @ParijatSen11 Reminds me of the iconic Satyajit Ray movie “Ashani Sanket”, a poignant portrayal of the tragedies during Bengal famine. https://t.co/9w1DDYz8jV
-
🚴♂️Join us for @columbiacancer Velocity Ride and help support our #Myeloma and #Amyoidosis research! @SLentzsch @DivayaB @CAMPamyloidosis https://t.co/niLQBYlXO1 https://t.co/r5XBYl1rH5